Home
Categories
Issues
2018
May 2018 - Vol 11 No 1
March 2018 - Vol 11 No 1
2017
November 2017 - Vol 10 No 6
September 2017 - Vol 10 No 5
July 2017 - Vol 10 No 4
May 2017 - Vol 10 No 3
March Vol 10 No 2
January Vol 10 No 1
2016
November Vol 9 No 6
September Vol 9 No 5
July Vol 9 No 4
May Vol 9 No 3
March Vol 9 No 2
January Vol 9 No 1
Issue Archive
Special Issues
2018 Guide to New FDA Approvals
Media Library
Video Library
TON Interview with the Innovators Series
Audiocast Library
News
In the News
Press Releases
Conference Correspondent
HNF 2018
ASH 2017 - ITP
SABCS 2017 - Breast Cancer
ONS 2017 - Immunotherapy
ASH 2016 - Roundup
ASH 2016 - Multiple Myeloma
ASH 2015 - Multiple Myeloma
CE
Resource
Online Only
Supplements
Quick Quiz
About
Contact Us
Editorial Board
Advertise
Wayne Kuznar
Authored Items
Ivosidenib, New IDH1 Inhibitor, Elicits Complete Response in Relapsed Acute Myeloid Leukemia
Wayne Kuznar
TON - March 2018, Vol 11, No 1
in
Conference Correspondent
,
Drug Updates & News
,
ASH
Quizartinib Combinations Show High Activity in Newly Diagnosed Acute Myeloid Leukemia with FLT3 Mutation
Wayne Kuznar
TON - March 2018, Vol 11, No 1
in
Conference Correspondent
,
Drug Updates & News
Selecting Optimal Therapy for Chronic Lymphocytic Leukemia Is a Work in Progress
Wayne Kuznar
TON - November 2017, Vol 10, No 6
in
Leukemia
Cediranib-Based Combination Therapy Extends Progression-Free Survival in Relapsed Ovarian Cancer
Wayne Kuznar
TOP - November 2017, Vol 10, No 4
in
Gynecologic Cancers
,
Online First
Olaparib First PARP Inhibitor to Show Advantage in BRCA-Positive Breast Cancers
Wayne Kuznar
TOP - November 2017, Vol 10, No 4
in
Breast Cancer
Osimertinib Extends Progression-Free Survival in EGFR T790M–Positive Lung Cancer with CNS Metastases Myeloma
Wayne Kuznar
TOP - November 2017, Vol 10, No 4
in
Lung Cancer
Updated NCCN Guidelines for Neuroendocrine Tumors and Carcinoid Syndrome Features New Therapies
Wayne Kuznar
TOP - August 2017, Vol 10, No 3
in
Conference Correspondent
,
NCCN News
Duloxetine Improves Chemotherapy-Induced Peripheral Neuropathy in Patients with Pancreatic Cancer
Wayne Kuznar
TOP - May 2017, Vol 10, No 2
in
Pancreatic Cancer
Direct Access to Colonoscopy Improves Screening Rates, Adenoma Detection
Wayne Kuznar
TON - March 2017, Vol 10, No 2
in
Colorectal Cancer
Daily Moderate Exercise Can Improve Outcomes in Patients with Metastatic Colorectal Cancer
Wayne Kuznar
TON - March 2017, Vol 10, No 2
in
Colorectal Cancer
Internet-Generated Survivorship Care Plans Are Convenient and Customized
Wayne Kuznar
TON - March 2017, Vol 10, No 2
in
Survivorship
Duloxetine Improves Chemotherapy-Induced Peripheral Neuropathy in Patients with Pancreatic Cancer
Wayne Kuznar
TON - March 2017, Vol 10, No 2
in
Rare Cancers
Triplet Therapy That Includes Elotuzumab Stops Progression of High-Risk Smoldering Multiple Myeloma
Wayne Kuznar
JHOP Web Exclusives
in
Conference Correspondent
,
ASH 2016 - Roundup
Venetoclax plus Bortezomib and Dexamethasone Produces High Responses in Relapsed or Refractory Multiple Myeloma
Wayne Kuznar
In the News: Oncology - February 2017
in
Conference Correspondent
Glasdegib, a Hedgehog Inhibitor, Nearly Doubles Survival in Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Wayne Kuznar
In the News: Oncology - February 2017
in
Conference Correspondent
Alectinib for First-Line Treatment in NSCLC with ALK Mutation
Wayne Kuznar
TOP - November 2016, Vol 9, No 4
in
Conference Correspondent
Minor Changes in Systemic Therapy Recommendations in NCCN Breast Cancer Guideline
Wayne Kuznar
TOP - August 2016, Vol 9, No 3
in
Guidelines
NCCN Survivorship Guidelines Update Management of Sexual Dysfunction in Cancer Survivors
Wayne Kuznar
TOP - August 2016, Vol 9, No 3
in
Guidelines
Promising Antitumor Activity of ODM-201 in Metastatic Prostate Cancer
Wayne Kuznar
TOP - August 2016, Vol 9, No 3
in
Genitourinary Cancers
NCCN Survivorship Guidelines Update Management of Sexual Dysfunction
Wayne Kuznar
TON July 2016 Vol 9 No 4
in
Guidelines
NCCN Panel Addresses Palliative Care Needs, Emphasizes Team Approach
Wayne Kuznar
TON July 2016 Vol 9 No 4
in
Palliative Care
Steroid Mouth Rinse Prevents Stomatitis with Everolimus
Wayne Kuznar
TON May 2016 Vol 9 No 3
in
Breast Cancer
Scan Underutilized in BRCA Carriers Undergoing Risk-Reducing Salpingo-Oophorectomy
Wayne Kuznar
TON May 2016 Vol 9 No 3
in
Conference Correspondent
Scalp Cooling System Lessens Chemotherapy-Induced Alopecia
Wayne Kuznar
TON May 2016 Vol 9 No 3
in
Breast Cancer
Text Messaging Application Helpful with Adherence to Endocrine Therapy
Wayne Kuznar
TOP - May 2016, Vol 9, No 2
in
Technology Update
Text Messaging Application Helpful with Adherence to Endocrine Therapy
Wayne Kuznar
TON March 2016 Vol 9 No 2
in
Technology Update
Counseling, Multiplex Testing May Lower Anxiety in At-Risk Patients with Cancer
Wayne Kuznar
TON March 2016 Vol 9 No 2
in
Genetic Counseling
Scalp Cooling System Lessens Chemotherapy-Induced Alopecia
Wayne Kuznar
TOP - February 2016, Vol 9, No 1
in
Breast Cancer
Oncology Medical Home Shows Significant Cost-Savings, Improved Care Delivery
Wayne Kuznar
TON January 2016 Vol 9 No 1
in
Navigation
Oncology Specialty Pharmacy Promotes the Coordination of Care
Wayne Kuznar
TOP November 2015 Vol 8 No 4
in
Practical Issues for Pharmacists
Molecular Pathways in Cancer Are Increasingly Being Exploited
Wayne Kuznar
TON November 2015 Vol 8 No 6
in
Personalized Medicine
Predictive Potential of Molecular Biomarkers Promises to Enhance Precision Medicine in Oncology
Wayne Kuznar
TON November 2015 Vol 8 No 6
in
Personalized Medicine
Immune Checkpoint Blockade Shows Durable Responses in Lung and Kidney Cancers, Metastatic Melanoma
Wayne Kuznar
TOP - August 2015, Vol 8, No 3
NCCN Issues New Smoking-Cessation Guidelines for Patients with Cancer
Wayne Kuznar
TOP - August 2015, Vol 8, No 3
in
Prevention
Treatment for CLL Will Incorporate More Targeted Therapies in the Near Future
Wayne Kuznar
TOP - August 2015, Vol 8, No 3
in
Hematologic Cancers
New NCCN Guideline Addresses Smoking Cessation in Patients With Cancer
Wayne Kuznar
TON May 2015 Vol 8 No 3
Vosaroxin, a Quinolone Derivative, Extends Survival in Older Patients with Acute Myeloid Leukemia
Wayne Kuznar
TOP - May 2015, Vol 8, No 2
in
Hematologic Cancers
Monitoring Response to TKI Therapy by PCR Improves Outcomes in Chronic Myeloid Leukemia
Wayne Kuznar
TOP - May 2015, Vol 8, No 2
in
Hematologic Cancers
Immunotherapy the Newest Breakthrough in Hodgkin Lymphoma
Wayne Kuznar
TOP - February 2015, Vol 8, No 1
in
Immunotherapy
Cancer Drug Pricing in the United States: What Is Driving the High Costs?
Wayne Kuznar
TOP - February 2015, Vol 8, No 1
in
Conference Correspondent
Routine Imaging Costly in B-Cell Lymphoma, Rarely Picks Up Relapse After Remission
Wayne Kuznar
TON - January 2015 Vol 8 No 1
in
Hematologic Cancers
Health Literacy
Wayne Kuznar
TOP - August 2014, Vol 7, No 3
in
Noteworthy Numbers
Worksite Pharmacy Can Enhance Overall Drug Management of Patients With Cancer
Wayne Kuznar
TOP - August 2014, Vol 7, No 3
in
Conference Correspondent
Exercise for Cancer Survivors
Wayne Kuznar
TON - July/August 2014 Vol 7 No 4
in
Conference Correspondent
Prospects for Personalization of Medicine Lie in Evidence Thresholds
Wayne Kuznar
TON - July/August 2014 Vol 7 No 4
in
Conference Correspondent
Skin Toxicity With Targeted Agents
Wayne Kuznar
TON - May/June 2014 Vol 7 No 3
in
Supportive Care
Skin Toxicity With Targeted Agents: Treatment With Antibiotics, Topical Steroids Often Sufficient
Wayne Kuznar
TOP - May 2014, Vol 7, No 2
in
Supportive Care
Molecular Monitoring Can Provide Treatment Guidance in CML
Wayne Kuznar
TOP - May 2014, Vol 7, No 2
in
Hematologic Cancers
Hormone Therapy Poses Health Risks in Patients With Prostate Cancer
Wayne Kuznar
TOP - May 2014, Vol 7, No 2
in
Hematologic Cancers
Molecular Therapy Beyond Sorafenib in HCC: New Pathways, Targets Being Explored
Wayne Kuznar
TOP - May 2014, Vol 7, No 2
in
Genitourinary Cancers
Promising Vaccine Combination Identified for Patients With Metastatic Pancreatic Cancer
Wayne Kuznar
TOP - May 2014, Vol 7, No 2
in
Rare Cancers
Immunotherapy Holds Promise to Extend Survival in GI Cancers
Wayne Kuznar
TOP - May 2014, Vol 7, No 2
in
Personalized Medicine
Investigational Angiogenesis Inhibitor Ramucirumab Improves Survival as Second-Line Treatment
Wayne Kuznar
TOP - May 2014, Vol 7, No 2
in
Gastrointestinal Cancers
Molecular Therapy Beyond Sorafenib in HCC: New Pathways, Targets Being Explored
Wayne Kuznar
TON - March/April 2014 Vol 7 No 2
in
Genitourinary Cancers
Prostate Cancer
Wayne Kuznar
TON - September 2013 Vol 6 No 8
in
Noteworthy Numbers
,
Hematologic Cancers
Novel Agents Emerge in Initial Therapy, Refractory Setting
Wayne Kuznar
TON - September 2013 Vol 6 No 8
in
Hematologic Cancers
Technology Brings No Upward Shift in Treatment of Local Prostate Cancer
Wayne Kuznar
TON - September 2013 Vol 6 No 8
in
Genitourinary Cancers
Monitor Adverse Events Early With Regorafenib, Especially After Initiation
Wayne Kuznar
TOP - May 2013, Vol 6, No 2
in
Supportive Care
Regorafenib Benefit in Colorectal Cancer Not Dependent on Mutations
Wayne Kuznar
TON - March 2013, Vol 6, No 2
in
Colorectal Cancer
Quality of Life Drives Patient Preference for Metastatic Renal Cell Carcinoma Drug
Wayne Kuznar
TOP - August 2012, Vol 5, No 5
Most End-of-Life Costs for Patients with Cancer Are Not Drug Related
Wayne Kuznar
TOP - September 2011 Vol 4, No 6
in
Conference Correspondent
Get Ready for the New Era of “Genomic Chaos” in Cancer Care
Wayne Kuznar
TOP - September 2011 Vol 4, No 6
in
Conference Correspondent
Decitabine Improves Overall Survival in Older AML Patients
Wayne Kuznar
TOP - August 2011 Vol 4, No 5
in
Conference Correspondent
,
Conference Correspondent
,
Hematologic Cancers
Treating Breakthrough Cancer Pain Requires Recognition, Matching Drug to Goal
Wayne Kuznar
TOP - Other
in
Supportive Care
Managing Hypersensitivity Reactions
Wayne Kuznar
TOP - Other
in
Supportive Care
Managing Hypersensitivity Reactions
Wayne Kuznar
TOP - Online
in
Supportive Care
Pharmacist Review of Palonosetron Use Has Potential to Capture Inappropriate Use and Save Money
Wayne Kuznar
TOP - Other
in
Drug Therapies
For Overweight Patients, Dosing Chemotherapy Based on Total Body Weight Does Not Lead to More Toxicities
Wayne Kuznar
TOP - Other
in
Gastrointestinal Cancers
Hospital Implements New Oral Chemotherapy Handling Process in Effort to Increase Safety
Wayne Kuznar
TOP - Other
Timing of Empiric Antibiotic Administration Affects Outcomes in Febrile Neutropenia
Wayne Kuznar
TOP - February 2011, Vol 4, No 1
Hospital Implements New Oral Chemotherapy Handling Process in Effort to Increase Safety
Wayne Kuznar
TOP - Online
Pharmacist Review of Palonosetron Use has Potential to Capture Inappropriate Use and Save Money
Wayne Kuznar
TOP - Online
For Overweight Patients, Dosing Chemotherapy Based on Total Body Weight Does Not Lead to More Toxicities
Wayne Kuznar
TOP - Online
Denosumab Prevents More Skeletal Events than Zoledronic Acid in Men with Prostate Cancer and Bone Metastases
Wayne Kuznar
TOP - Other
Naproxen Reduces Bone Pain after Pegfilgrastim Injection
Wayne Kuznar
TOP - Other
Risk Factors for Chemotherapy Toxicity in Elderly are Identified
Wayne Kuznar
TOP - Online
Fentanyl Nasal Spray Beats Oral Opioid for Control of Rreakthrough Cancer Pain
Wayne Kuznar
TOP - Online
Naproxen Reduces Bone Pain After Pegfilgrastim Injection
Wayne Kuznar
TOP - Online
Bevacizumab Lengthens Progression-free Survival in Advanced Ovarian Cancer
Wayne Kuznar
TOP - Online
Last modified: June 10, 2010
Sign Up Now!
To sign up for our newsletter or print publications, enter your contact information below.
First Name
Last Name
Address
Address (Continued)
City
State/Province
ZIP/Postal Code
Country
Afghanistan
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia and Herzegowina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos Keeling Islands
Colombia
Comoros
Congo
Congo, Democratic Republic of the
Cook Islands
Costa Rica
Cote d'Ivoire
Croatia Hrvatska
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
East Timor
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands Malvinas
Faroe Islands
Fiji
Finland
France
France, Metropolitan
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guinea
Guinea-Bissau
Guyana
Haiti
Jamaica
Holy See (Vatican City State)
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran, Islamic Republic of
Iraq
Ireland
Israel
Italy
Japan
Jordan
Kazakhstan
Kenya
Kiribati
Korea, Democratic People's Republic of
Korea, Republic of
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libyan Arab Jamahiriya
Liechtenstein
Lithuania
Luxembourg
Macau
Macedonia, The Former Yugoslav Republic of
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia, Federated States of
Moldova, Republic of
Monaco
Mongolia
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Reunion
Romania
Russian Federation
Rwanda
Saint Kitts and Nevis
Saint LUCIA
Saint Vincent and the Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Senegal
Seychelles
Sierra Leone
Singapore
Slovakia (Slovak Republic)
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and the South Sandwich Islands
Spain
Sri Lanka
St. Helena
St. Pierre and Miquelon
Sudan
Suriname
Svalbard and Jan Mayen Islands
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Taiwan, Province of China
Tajikistan
Tanzania, United Republic of
Thailand
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela
Viet Nam
Virgin Islands (British)
Virgin Islands (U.S.)
Wallis and Futuna Islands
Western Sahara
Yemen
Yugoslavia
Zambia
Zimbabwe
Print Edition
E-Newsletters & Communications
I have reviewed and consent to the terms of
TON
's
Privacy Policy
, and
TON
has my permission to retain my information in its database, and to forward pertinent communications to me.
Home
Categories
Issues
2018
May 2018 - Vol 11 No 1
March 2018 - Vol 11 No 1
2017
November 2017 - Vol 10 No 6
September 2017 - Vol 10 No 5
July 2017 - Vol 10 No 4
May 2017 - Vol 10 No 3
March Vol 10 No 2
January Vol 10 No 1
2016
November Vol 9 No 6
September Vol 9 No 5
July Vol 9 No 4
May Vol 9 No 3
March Vol 9 No 2
January Vol 9 No 1
Issue Archive
Special Issues
2018 Guide to New FDA Approvals
Media Library
Video Library
TON Interview with the Innovators Series
Audiocast Library
News
In the News
Press Releases
Conference Correspondent
HNF 2018
ASH 2017 - ITP
SABCS 2017 - Breast Cancer
ONS 2017 - Immunotherapy
ASH 2016 - Roundup
ASH 2016 - Multiple Myeloma
ASH 2015 - Multiple Myeloma
CE
Resource
Online Only
Supplements
Quick Quiz
About
Contact Us
Editorial Board
Advertise
